Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

  1. Mackey, J.R.
  2. Pieńkowski, T.
  3. Crown, J.
  4. Sadeghi, S.
  5. Martin, M.
  6. Chan, A.
  7. Saleh, M.
  8. Sehdev, S.
  9. Provencher, L.
  10. Semiglazov, V.
  11. Press, M.F.
  12. Sauter, G.
  13. Lindsay, M.
  14. Houé, V.
  15. Buyse, M.
  16. Drevot, P.
  17. Hitier, S.
  18. Bensfia, S.
  19. Eiermann, W.
Journal:
Annals of Oncology

ISSN: 1569-8041 0923-7534

Year of publication: 2016

Volume: 27

Issue: 6

Pages: 1041-1047

Type: Article

DOI: 10.1093/ANNONC/MDW098 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals